HomeGOVX • NASDAQ
add
Geovax Labs Inc
Nakaraang pagsara
$1.92
Sakop ng araw
$1.75 - $1.91
Sakop ng taon
$1.09 - $11.18
Market cap
15.26M USD
Average na Volume
801.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 300.68K | — |
Gastos sa pagpapatakbo | 1.09M | -25.57% |
Net na kita | -5.06M | 14.57% |
Net profit margin | -1.68K | — |
Kita sa bawat share | — | — |
EBITDA | -5.04M | 18.23% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.56M | -91.22% |
Kabuuang asset | 4.10M | -80.73% |
Kabuuang sagutin | 6.40M | 56.76% |
Kabuuang equity | -2.31M | — |
Natitirang share | 5.26M | — |
Presyo para makapag-book | -3.49 | — |
Return on assets | -339.60% | — |
Return on capital | 1,198.07% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.06M | 14.57% |
Cash mula sa mga operasyon | -1.94M | 67.85% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 2.73M | — |
Net change in cash | 792.85K | 113.08% |
Malayang cash flow | -273.26K | 93.08% |
Tungkol
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
Itinatag
1988
Headquarters
Website
Mga Empleyado
17
